IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 42 filers reported holding IMMUNOVANT INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,736,366 | -39.9% | 644,344 | -27.7% | 0.66% | -24.1% |
| Q4 2020 | $41,155,000 | +57.5% | 891,000 | +20.0% | 0.87% | +31.7% |
| Q3 2020 | $26,127,000 | +137.2% | 742,449 | +64.1% | 0.66% | +119.5% |
| Q2 2020 | $11,014,000 | +183.1% | 452,319 | +80.9% | 0.30% | +87.6% |
| Q1 2020 | $3,891,000 | – | 250,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 1,439,544 | $22,327,327 | 8.67% |
| Logos Global Management LP | 2,500,000 | $38,775,000 | 5.55% |
| Deep Track Capital, LP | 7,432,717 | $115,281,441 | 4.74% |
| COMMODORE CAPITAL LP | 1,440,999 | $22,349,894 | 3.40% |
| Ikarian Capital, LLC | 774,398 | $12,010,913 | 2.72% |
| COWEN AND COMPANY, LLC | 1,250,000 | $19,387,500 | 2.28% |
| HighVista Strategies LLC | 163,799 | $2,540,522 | 2.07% |
| TCG Crossover Management, LLC | 654,853 | $10,156,770 | 1.98% |
| BVF INC/IL | 2,561,000 | $39,721,110 | 1.45% |
| Redmile Group, LLC | 1,317,031 | $20,427,151 | 0.89% |